{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:46:48Z","timestamp":1793321208520,"version":"4.5.0"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Toll-like receptor 4 (TLR4) and myeloid differentiation factor 88 (MyD88) signaling play a critical role in colorectal cancer (CRC) development. Despite extensive research, the relationship between genetic variations and protein expression patterns during adenoma-carcinoma progression remains poorly understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a cross-sectional study of 176 CRC patients and 131 adenoma patients. Inclusion criteria required histologically confirmed primary colorectal tumors with adequate tissue content (\u226530% tumor cells). TLR4 and MyD88 protein expression was evaluated using immunohistochemistry with standardized scoring systems. DNA sequencing identified genetic variants in TLR4 and MyD88 genes. Multivariate analyses assessed associations between protein expression, genetic variants, and clinicopathological features.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>TLR4 expression was significantly higher in CRC compared to adenomas (66.5% vs 30.5%, p&amp;lt;0.001), with MyD88 showing widespread expression in both groups (CRC: 97.2%, adenoma: 95.4%). We identified novel variants in TLR4 (9:117713042) and MyD88 (rs138284536), significantly associated with increased CRC risk (OR=8.92, 95% CI: 1.14-69.95, p=0.037 and OR=20.01, 95% CI: 4.72-84.83, p&amp;lt;0.001, respectively). The MyD88 variant correlated with aggressive features including mucinous histology (43.5% vs 22.7%, p=0.036), advanced pT stage (29.6% vs 13.2%, p=0.044), and perineural invasion (61.5% vs 22.1%, p=0.004). Combined TLR4\/MyD88 scores \u22655 significantly predicted lymph node metastasis (42.9% vs 28.3%, p=0.046) and high-grade tumor budding (p=0.002).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study identifies distinct TLR4\/MyD88 expression patterns in CRC progression and novel genetic variants associated with aggressive tumor features. These molecular alterations may serve as potential biomarkers for risk stratification and prognostic assessment in CRC patients, while offering promising targets for therapeutic intervention.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1568729","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T05:47:08Z","timestamp":1752126428000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["TLR4\/MyD88 expression patterns and novel genetic variants: association with aggressive clinicopathological features in colorectal cancer"],"prefix":"10.3389","volume":"15","author":[{"given":"Thai Tra","family":"Dang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viet Nhat","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc Dung","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu Hang","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van Mao","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy Hoang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Xuan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Chung","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5114\/pg.2018.81072","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Prz Gastroenterol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.5604\/17322693.1200551","article-title":"The role of inflammation in colon cancer pathogenesis","volume":"70","author":"Francuz","year":"2016","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092729","article-title":"The cancer prevention, anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway","volume":"19","author":"Chen","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605558","article-title":"High expression of Toll-like receptor 4\/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer","volume":"102","author":"Wang","year":"2010","journal-title":"Br J cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210908","article-title":"Role of Toll-like receptors in gastrointestinal Malignancies","volume":"27","author":"Fukata","year":"2008","journal-title":"Oncogene"},{"key":"B10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4049\/jimmunol.170.2.795","article-title":"Endotoxin\/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism","volume":"170","author":"Wang","year":"2003","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.09.008","article-title":"Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors","volume":"133","author":"Fukata","year":"2007","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0784","article-title":"Toll-like receptors on tumor cells facilitate evasion of immune surveillance","volume":"65","author":"Huang","year":"2005","journal-title":"Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/ibd.20880","article-title":"Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors","volume":"15","author":"Fukata","year":"2009","journal-title":"Inflammation Bowel Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146333","article-title":"Expression and polymorphism of toll-like receptor 4 and effect on NF-\u03baB mediated inflammation in colon cancer patients","volume":"11","author":"Semlali","year":"2016","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2012.08.006","article-title":"Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans","volume":"45","author":"Pimentel-Nunes","year":"2013","journal-title":"Digestive Liver Disease"},{"key":"B16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrc2541","article-title":"Toll-like receptors and cancer","volume":"9","author":"Rakoff-Nahoum","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1746","article-title":"Functional TLR5 genetic variants affect human colorectal cancer survival","volume":"73","author":"Klimosch","year":"2013","journal-title":"Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-013-1075-6","article-title":"Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis","volume":"35","author":"Omrane","year":"2014","journal-title":"Tumour Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12307-009-0022-y","article-title":"Cancer cells expressing toll-like receptors and the tumor microenvironment","author":"Sato","year":"2009","journal-title":"Cancer Microenviron"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1210164","article-title":"Immune escape and resistance to immunotherapy in mismatch repair deficient tumors","volume":"14","author":"Mestrallet","year":"2023","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2020-0047-ra","article-title":"Recent advances in digestive tract tumors: updates from the 5th edition of the world health organization \u201cBlue book","volume":"145","author":"Gonzalez","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up&x2020;","volume":"31","author":"Argil\u00e9s","year":"2020","journal-title":"Ann Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.46","article-title":"Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016","volume":"30","author":"Lugli","year":"2017","journal-title":"Mod Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0000000000000162","article-title":"Assessing tumor-infiltrating lymphocytes in solid tumors: A practical review for pathologists and proposal for a standardized method from the international immunooncology biomarkers working group: part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/cjp2.120","article-title":"Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation","volume":"5","author":"McCarthy","year":"2019","journal-title":"J Pathol Clin Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00060","article-title":"Regulation of intestinal immune responses through TLR activation: implications for pro- and prebiotics","volume":"5","author":"de Kivit","year":"2014","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04199-4","article-title":"Contribution of TLR4 to colorectal tumor microenvironment, etiology and prognosis","volume":"149","author":"Crame","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1244345","article-title":"Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives","volume":"14","author":"Mukherjee","year":"2023","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S50838","article-title":"Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers","volume":"6","author":"Mai","year":"2013","journal-title":"OncoTargets Ther"},{"key":"B32","article-title":"Significance of TLR4\/MyD88 expression in breast cancer","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2013.03.008","article-title":"MyD88 and its divergent toll in carcinogenesis","volume":"34","author":"Salcedo","year":"2013","journal-title":"Trends Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604942","article-title":"Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system","volume":"100","author":"Killeen","year":"2009","journal-title":"Br J cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24899","article-title":"Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for Malignant melanoma","volume":"116","author":"Hino","year":"2010","journal-title":"Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007583","article-title":"TLR4 signaling improves PD-1 blockade therapy during chronic viral infection","volume":"15","author":"Wang","year":"2019","journal-title":"PLoS Pathog"},{"key":"B37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00535-011-0523-6","article-title":"The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models","volume":"47","author":"Oshima","year":"2012","journal-title":"J gastroenterol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12979-023-00383-3","article-title":"Toll-like receptor 4 (TLR4): new insight immune and aging","volume":"20","author":"Kim","year":"2023","journal-title":"Immun Ageing"},{"key":"B39","doi-asserted-by":"publisher","first-page":"154673","DOI":"10.1016\/j.prp.2023.154673","article-title":"Implications of Toll-like receptors (TLRs) and their signaling mechanisms in human cancers","volume":"248","author":"Chandrasekar","year":"2023","journal-title":"Pathol - Res Practice"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2833","article-title":"LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis","volume":"71","author":"Hsu","year":"2011","journal-title":"Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.10.1472","article-title":"Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells","volume":"52","author":"Sheng","year":"2003","journal-title":"Gut"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32904","article-title":"NF\u03baB signalling in colorectal cancer: Examining the central dogma of IKK\u03b1 and IKK\u03b2 signalling","volume":"10","author":"McKenzie","year":"2024","journal-title":"Heliyon"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1099811","article-title":"Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells","volume":"13","author":"Jin","year":"2023","journal-title":"Front Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/j.gastro.2010.04.045","article-title":"Pathogenic and protective roles of myD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease","volume":"139","author":"Asquith","year":"2010","journal-title":"Gastroenterology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcmgh.2014.11.006","article-title":"Mechanisms of immune signaling in colitis-associated cancer","volume":"1","author":"Waldner","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1157023","DOI":"10.1155\/2021\/1157023","article-title":"Toll-like receptors (TLRs): structure, functions, signaling, and role of their polymorphisms in colorectal cancer susceptibility","volume":"2021","author":"Sameer","year":"2021","journal-title":"BioMed Res Int"},{"key":"B47","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/biom14050562","article-title":"MyD88 and its inhibitors in cancer: prospects and challenges","volume":"14","author":"Song","year":"2024","journal-title":"Biomolecules"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt120","article-title":"MyD88 in DNA repair and cancer cell resistance to genotoxic drugs","volume":"105","author":"Kfoury","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1525","article-title":"MYD88 L265P mutations, but no other variants, identify a subpopulation of DLBCL patients of activated B-cell origin, extranodal involvement, and poor outcome","volume":"22","author":"Rovira","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12943-024-02194-6","article-title":"Advances in A-to-I RNA editing in cancer","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235885","article-title":"The role of innate immune cells in tumor invasion and metastasis","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24396","article-title":"Perineural invasion in cancer: a review of the literature","volume":"115","author":"Liebig","year":"2009","journal-title":"Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16233928","article-title":"Prognostic and predictive determinants of colorectal cancer: A comprehensive review","volume":"16","author":"Cotan","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46020062","article-title":"Nerve growth factor and the role of inflammation in tumor development","volume":"46","author":"Ferraguti","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1021\/jm401006s","article-title":"Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update","volume":"57","author":"Peri","year":"2014","journal-title":"J Med Chem"},{"key":"B57","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","article-title":"Pre-metastatic niche: formation, characteristics and therapeutic implication","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3525","article-title":"The role of TLR4 in chemotherapy-driven metastasis","volume":"75","author":"Ran","year":"2015","journal-title":"Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8586","article-title":"Activation of the TLR4\/MyD88 signaling pathway contributes to the development of human hepatocellular carcinoma via upregulation of IL-23 and IL-17A","volume":"15","author":"Kang","year":"2018","journal-title":"Oncol Lett"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2018-0082-RA","article-title":"Tumor budding in colorectal carcinoma: translating a morphologic score into clinically meaningful results","volume":"142","author":"Cho","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00429","article-title":"The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition","volume":"5","author":"Luddy","year":"2014","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914815","article-title":"Role of epithelial to mesenchymal transition in colorectal cancer","volume":"24","author":"Lu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae152","article-title":"Predictors of response to immunotherapy in colorectal cancer","volume":"29","author":"Gonz\u00e1lez-Montero","year":"2024","journal-title":"Oncologist"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004717","article-title":"Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy","volume":"10","author":"Krieg","year":"2022","journal-title":"J ImmunoTherapy Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.4c00008","article-title":"Advances in precision medicine approaches for colorectal cancer: from molecular profiling to targeted therapies","volume":"7","author":"Kiran","year":"2024","journal-title":"ACS Pharmacol Trans Science"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2019.10.013","article-title":"Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine","volume":"8","author":"Singh","year":"2021","journal-title":"Genes Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1336696","article-title":"MyD88 signaling pathways: role in breast cancer","volume":"14","author":"Zheng","year":"2024","journal-title":"Front Oncol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2147\/BCTT.S489246","article-title":"Exploring the complexity of pan-cancer: gene convergences and in silico analyses","volume":"16","author":"Teodoro","year":"2024","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"B69","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.3747\/co.26.5605","article-title":"Adjuvant therapy for stages II and III colon cancer: risk stratification, treatment duration, and future directions","volume":"26","author":"Bender","year":"2019","journal-title":"Curr Oncol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30070480","article-title":"Strategic insight into the combination therapies for metastatic colorectal cancer","volume":"30","author":"Kano","year":"2023","journal-title":"Curr Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1568729\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T12:13:12Z","timestamp":1752149592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1568729\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":70,"alternative-id":["10.3389\/fonc.2025.1568729"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1568729","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"article-number":"1568729"}}